Real-World clinical outcomes of asthma patients switched from reslizumab to mepolizumab or benralizumab.
Frontiers in allergy(2022)
摘要
We present real-world clinical outcomes of asthma patients switched from reslizumab to either benralizumab or mepolizumab without a loss of clinical effectiveness in the majority.
更多查看译文
关键词
ACQ,asthma,biological therapy,exacerbation,real-word
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要